乳腺癌患者-话题@MedSci

#乳腺癌患者#

488篇内容 | 1972人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2199984, encodeId=67742199984a0, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=【热点解读】乳腺癌患者乳房重建决策指导的最佳证据总结, objectType=article, longId=822914, objectId=71b982291423, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679882276618_4754896.png, objectUrl=/article/show_article.do?id=71b982291423, replyNumber=0, likeNumber=0, createdTime=2024-04-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=71b982291423, moduleTitle=【热点解读】乳腺癌患者乳房重建决策指导的最佳证据总结, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71b982291423)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1571354, encodeId=7d0415e1354d7, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=非HER2阳性的乳腺癌患者辅助治疗, objectType=article, longId=736057, objectId=8bf7e36057de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bf7e36057de, replyNumber=0, likeNumber=51, createdTime=2022-08-18, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bf7e36057de, moduleTitle=非HER2阳性的乳腺癌患者辅助治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bf7e36057de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571353, encodeId=c7aa15e1353cb, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=European Radiology：在接受NAC的乳腺癌患者中，测量这一影像学指标可预测化疗相关脂肪性肝炎！, objectType=article, longId=735944, objectId=edb5e359444e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edb5e359444e, replyNumber=0, likeNumber=41, createdTime=2022-08-17, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edb5e359444e, moduleTitle=European Radiology：在接受NAC的乳腺癌患者中，测量这一影像学指标可预测化疗相关脂肪性肝炎！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edb5e359444e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571351, encodeId=c3da15e13513d, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=对这部分早期乳腺癌患者而言，辅助化疗无益！甚至有害！, objectType=article, longId=735743, objectId=6756e3574339, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6756e3574339, replyNumber=0, likeNumber=44, createdTime=2022-08-14, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6756e3574339, moduleTitle=对这部分早期乳腺癌患者而言，辅助化疗无益！甚至有害！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6756e3574339)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571350, encodeId=b62b15e13505b, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=FDA提前4个月加速批准DS-8201治疗HER2低表达乳腺癌，超6成乳腺癌患者均能受益, objectType=article, longId=735119, objectId=7ff5e35119bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ff5e35119bc, replyNumber=0, likeNumber=48, createdTime=2022-08-09, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ff5e35119bc, moduleTitle=FDA提前4个月加速批准DS-8201治疗HER2低表达乳腺癌，超6成乳腺癌患者均能受益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ff5e35119bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571349, encodeId=9efe15e1349cb, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=J Clin Oncol：戈舍瑞林和他莫西芬辅助治疗绝经前乳腺癌患者的长期益处, objectType=article, longId=734127, objectId=c1d5e3412727, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1d5e3412727, replyNumber=0, likeNumber=43, createdTime=2022-08-03, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1d5e3412727, moduleTitle=J Clin Oncol：戈舍瑞林和他莫西芬辅助治疗绝经前乳腺癌患者的长期益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1d5e3412727)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571352, encodeId=027515e1352c6, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=不吃药不打针，每周2.5小时，死亡风险降7成！运动能为乳腺癌患者带来哪些好处？, objectType=article, longId=733753, objectId=fd05e3375388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd05e3375388, replyNumber=0, likeNumber=50, createdTime=2022-07-30, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd05e3375388, moduleTitle=不吃药不打针，每周2.5小时，死亡风险降7成！运动能为乳腺癌患者带来哪些好处？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd05e3375388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571348, encodeId=ebb115e13480a, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=JACC子刊：热门饮食法再立奇功！可令老年乳腺癌患者心血管疾病风险降低15%！, objectType=article, longId=732350, objectId=b832e3235086, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b832e3235086, replyNumber=0, likeNumber=42, createdTime=2022-07-15, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b832e3235086, moduleTitle=JACC子刊：热门饮食法再立奇功！可令老年乳腺癌患者心血管疾病风险降低15%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b832e3235086)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571347, encodeId=fc9d15e1347dc, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=Ther Adv Med Oncol：洛铂新辅助治疗可改善三阴性乳腺癌患者预后, objectType=article, longId=731076, objectId=fee6e3107677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fee6e3107677, replyNumber=0, likeNumber=44, createdTime=2022-07-03, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fee6e3107677, moduleTitle=Ther Adv Med Oncol：洛铂新辅助治疗可改善三阴性乳腺癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fee6e3107677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571346, encodeId=93b015e134661, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=NEJM：ADC药物效果惊艳，延长晚期乳腺癌患者无进展生存期50%, objectType=article, longId=728906, objectId=8ed1e2890609, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ed1e2890609, replyNumber=0, likeNumber=57, createdTime=2022-06-10, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ed1e2890609, moduleTitle=NEJM：ADC药物效果惊艳，延长晚期乳腺癌患者无进展生存期50%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ed1e2890609)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571344, encodeId=df3815e134495, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=JAMA：二甲双胍面对乳腺癌，没了“神通”！三期临床研究显示，非糖尿病早期乳腺癌患者服用二甲双胍进行辅助治疗，无法改善生存, objectType=article, longId=728397, objectId=e43be283979e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e43be283979e, replyNumber=0, likeNumber=58, createdTime=2022-06-02, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e43be283979e, moduleTitle=JAMA：二甲双胍面对乳腺癌，没了“神通”！三期临床研究显示，非糖尿病早期乳腺癌患者服用二甲双胍进行辅助治疗，无法改善生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e43be283979e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571345, encodeId=26a715e134553, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=2022 ASCO：内分泌疗法±辅助化疗治疗ER+HER2-老年乳腺癌患者的长期预后, objectType=article, longId=728383, objectId=8dade283838d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dade283838d, replyNumber=0, likeNumber=46, createdTime=2022-06-02, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dade283838d, moduleTitle=2022 ASCO：内分泌疗法±辅助化疗治疗ER+HER2-老年乳腺癌患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8dade283838d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571343, encodeId=09f615e1343e2, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=ASCO 2022 | 心脏代谢和腹部脂肪对女性乳腺癌患者身体功能的影响, objectType=article, longId=728356, objectId=f01ee283560f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f01ee283560f, replyNumber=0, likeNumber=50, createdTime=2022-06-02, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f01ee283560f, moduleTitle=ASCO 2022 | 心脏代谢和腹部脂肪对女性乳腺癌患者身体功能的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f01ee283560f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571342, encodeId=588915e13429f, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=JAMA:二甲双胍对非糖尿病乳腺癌患者侵袭性疾病生存率的影响, objectType=article, longId=727994, objectId=6942e279944e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6942e279944e, replyNumber=0, likeNumber=61, createdTime=2022-05-29, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6942e279944e, moduleTitle=JAMA:二甲双胍对非糖尿病乳腺癌患者侵袭性疾病生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6942e279944e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571341, encodeId=de9215e134159, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=BMC Cancer：质子泵抑制剂(PPIs)可降低转移性乳腺癌患者使用palbociclib和 ribociclib治疗的疗效, objectType=article, longId=727632, objectId=94b4e2763255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94b4e2763255, replyNumber=0, likeNumber=36, createdTime=2022-05-25, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94b4e2763255, moduleTitle=BMC Cancer：质子泵抑制剂(PPIs)可降低转移性乳腺癌患者使用palbociclib和 ribociclib治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94b4e2763255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571339, encodeId=9ab815e1339f8, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据, objectType=article, longId=726291, objectId=eddae262914c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eddae262914c, replyNumber=0, likeNumber=39, createdTime=2022-05-08, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eddae262914c, moduleTitle=Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eddae262914c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571340, encodeId=b8b315e134093, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=Front Psychiatry：用中药治疗乳腺癌患者的长期溃疡，一个病例报告, objectType=article, longId=726154, objectId=5ba6e2615404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ba6e2615404, replyNumber=0, likeNumber=48, createdTime=2022-05-06, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ba6e2615404, moduleTitle=Front Psychiatry：用中药治疗乳腺癌患者的长期溃疡，一个病例报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ba6e2615404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571337, encodeId=8bc615e1337b2, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=European Radiology：MRI在预测乳腺癌患者新辅助化疗病理完全缓解的价值, objectType=article, longId=723939, objectId=1761e2393961, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1761e2393961, replyNumber=0, likeNumber=48, createdTime=2022-04-11, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1761e2393961, moduleTitle=European Radiology：MRI在预测乳腺癌患者新辅助化疗病理完全缓解的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1761e2393961)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571336, encodeId=928815e1336c8, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=European Radiology：MRI对新辅助化疗乳腺癌患者病理完全缓解的预测, objectType=article, longId=723739, objectId=f9e9e23739fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9e9e23739fe, replyNumber=0, likeNumber=48, createdTime=2022-04-08, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9e9e23739fe, moduleTitle=European Radiology：MRI对新辅助化疗乳腺癌患者病理完全缓解的预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9e9e23739fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1571334, encodeId=162415e133430, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, objectTitle=Cancer：ER阳性低表达（IHC 1%-10%）乳腺癌患者短程（2-3年）辅助内分泌治疗是可选择的治疗方案, objectType=article, longId=723583, objectId=9000e235839c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9000e235839c, replyNumber=0, likeNumber=45, createdTime=2022-04-07, rootId=0, userName=hanhaisha2013, userId=37bc15724202, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9000e235839c, moduleTitle=Cancer：ER阳性低表达（IHC 1%-10%）乳腺癌患者短程（2-3年）辅助内分泌治疗是可选择的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9000e235839c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

乳腺癌患者

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#乳腺癌患者#

【热点解读】乳腺癌患者乳房重建决策指导的最佳证据总结

2024-04-23发表于上海

zhaojie88 (审核中...)

前往app查看评论内容

#乳腺癌患者#

非HER2阳性的乳腺癌患者辅助治疗

2022-08-18

zhaojie88 (审核中...)

前往app查看评论内容

#乳腺癌患者#

European Radiology：在接受NAC的乳腺癌患者中，测量这一影像学指标可预测化疗相关脂肪性肝炎！

2022-08-17

zhaojie88 (审核中...)

前往app查看评论内容

#乳腺癌患者#

对这部分早期乳腺癌患者而言，辅助化疗无益！甚至有害！

2022-08-14

zhaojie88 (审核中...)

前往app查看评论内容

#乳腺癌患者#

FDA提前4个月加速批准DS-8201治疗HER2低表达乳腺癌，超6成乳腺癌患者均能受益

2022-08-09

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

J Clin Oncol：戈舍瑞林和他莫西芬辅助治疗绝经前乳腺癌患者的长期益处

2022-08-03

zhaojie88 (审核中...)

前往app查看评论内容

#乳腺癌患者#

不吃药不打针，每周2.5小时，死亡风险降7成！运动能为乳腺癌患者带来哪些好处？

2022-07-30

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

JACC子刊：热门饮食法再立奇功！可令老年乳腺癌患者心血管疾病风险降低15%！

2022-07-15

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

Ther Adv Med Oncol：洛铂新辅助治疗可改善三阴性乳腺癌患者预后

2022-07-03

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

NEJM：ADC药物效果惊艳，延长晚期乳腺癌患者无进展生存期50%

2022-06-10

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

JAMA：二甲双胍面对乳腺癌，没了“神通”！三期临床研究显示，非糖尿病早期乳腺癌患者服用二甲双胍进行辅助治疗，无法改善生存

2022-06-02

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

2022 ASCO：内分泌疗法±辅助化疗治疗ER+HER2-老年乳腺癌患者的长期预后

2022-06-02

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

ASCO 2022 | 心脏代谢和腹部脂肪对女性乳腺癌患者身体功能的影响

2022-06-02

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

JAMA:二甲双胍对非糖尿病乳腺癌患者侵袭性疾病生存率的影响

2022-05-29

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

BMC Cancer：质子泵抑制剂(PPIs)可降低转移性乳腺癌患者使用palbociclib和 ribociclib治疗的疗效

2022-05-25

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据

2022-05-08

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

Front Psychiatry：用中药治疗乳腺癌患者的长期溃疡，一个病例报告

2022-05-06

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

European Radiology：MRI在预测乳腺癌患者新辅助化疗病理完全缓解的价值

2022-04-11

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

European Radiology：MRI对新辅助化疗乳腺癌患者病理完全缓解的预测

2022-04-08

hanhaisha2013 (审核中...)

前往app查看评论内容

#乳腺癌患者#

Cancer：ER阳性低表达（IHC 1%-10%）乳腺癌患者短程（2-3年）辅助内分泌治疗是可选择的治疗方案

2022-04-07

科室
- - 订阅+
  - 更多科室
工具
服务